Battamir Ulambayar

Dr. Battamir Ulambayar

Department of Health Informatics, University of Debrecen, Debrecen, Hajdú-Bihar, Hungary
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Battamir UlambayarBattamir Ulambayar
Battamir Ulambayar
Amr Sayed GhanemAmr Sayed Ghanem
Amr Sayed Ghanem
ÁTÁgnes Tóth
Ágnes Tóth
ANAttila Nagy
Attila Nagy
Background: The prevalence of diabetes mellitus (DM) is increasing worldwide, and mental health problems such as depression, anxiety, and diabetes distress are common co-morbidities that negatively impact the quality of life, complications, and treatment outcomes of patients with DM. Objectives: In this study, we assessed the impact of dietary patterns and physical activity on the well-being of patients with DM. Methods: A cross-sectional design and data from the European Health Interview Survey (EHIS) data collected in Hungary in 2019, and determination of the relationship between dietary habits and physical activity-related variables contained in the data and the World Health Organization-Five Well-Being Index (WHO-5 index) by suitable statistical methods. Results: Logistic regression showed higher odds of poor mental well-being in females (OR = 1.61, 95% CI: 1.08–2.42) and lower odds with daily fruit intake (OR = 0.52, 95% CI: 0.31–0.89). Infrequent white meat (OR = 3.34, 95% CI: 1.35–8.22) and dairy intake (OR = 1.60, 95% CI: 1.18–2.64) were associated with poorer well-being. Walking 4–7 days/week reduced the odds by 57% (OR = 0.43, 95% CI: 0.23–0.83). Conclusions: The results demonstrate that regular exercise and the consumption of fruits, dairy products, and white meat have beneficial effects on the mental well-being of patients with DM.

Verified
Journal Article
Open access
PDF file
Battamir UlambayarBattamir Ulambayar
Battamir Ulambayar
Amr Sayed GhanemAmr Sayed Ghanem
Amr Sayed Ghanem
CNChau Minh Nguyen
Chau Minh Nguyen
EFEszter Faludi
Eszter Faludi
MMMarianna Móré
Marianna Móré
ANAttila Nagy
Attila Nagy
Background: Cardiovascular diseases (CVD) are the main cause of death in the population with diabetes mellitus. This study purposed to determine clinical laboratory markers that might be correlated with the risk of CVD in individuals with type 2 diabetes mellitus (T2DM). Methods: Using data from the Clinical Center of the University of Debrecen from 2016 to 2020, we assessed cardiovascular risk in 5593 individuals with T2DM over a five-year follow-up period. There were 347 new cases of acute myocardial infarction (AMI) and stroke during the period. Following the stratification of these individuals into two groups according to the diagnosis of these CVDs until 2020, the risk of these CVDs was assessed through the utilization of the Chi-square test and Cox proportional hazards regression. Results: The findings of the Cox proportional hazards regression model showed that the number of HbA1C measurements per year (HR = 0.46, 95% CI 0.31–0.7), decreased levels of estimated glomerular filtration rate (eGFR) (HR = 1.6, 95% CI 1.04–2.47), and elevated triglyceride levels (HR = 1.56, 95% CI 1.06–2.29) were correlated with CVD in patients with T2DM. The area under the curve (AUC) was increased from 0.557 (95% CI 0.531–0.582) to 0.628 (95% CI 0.584–0.671) after the inclusion of the laboratory variables into the model showing improved discrimination for AMI and stroke. Conclusions: These findings indicated that eGFR, triglyceride, and the number of HbA1C per year are correlated with AMI and stroke in patients with T2DM.

Verified
Journal Article
Open access
PDF file
Battamir UlambayarBattamir Ulambayar
Battamir Ulambayar
ANAttila Nagy
Attila Nagy
Background/Objectives: Cardiovascular disease (CVD) remains a leading cause of mortality in Hungary, with rising obesity and diabetes rates exacerbating the burden. Artificial sweeteners, promoted as healthier alternatives to sugar, have been linked to CVD risk in other populations, but evidence in Hungary is limited. This study aims to investigate the association between artificial sweetener use and CVD prevalence in a Hungarian population, independent of traditional risk factors, using data from the 2019 European Health Interview Survey (EHIS). Methods: This cross-sectional study analyzed EHIS data (n = 5603), categorizing participants by self-reported CVD diagnoses (hypertension, coronary artery disease, myocardial infarction, or stroke). Variables included artificial sweetener use, age, sex, education, income, smoking, alcohol consumption, physical activity, diabetes, and body mass index (BMI). Chi-square tests and multivariate logistic regression, adjusted for sampling weights, were employed to assess associations. Results: Of 5603 participants, 38.7% had CVD and 16.4% used artificial sweeteners. Older age, female sex, lower education, long-term smoking cessation, obesity, diabetes, and physical inactivity increased CVD risk, while moderate alcohol consumption and sports were protective. Artificial sweetener use was significantly associated with higher CVD prevalence (OR: 1.21, 95% CI: 1.01–1.46, p = 0.01), independent of other risk factors. Conclusions: Artificial sweetener use is associated with increased CVD risk in Hungary, suggesting a need for further research and public health strategies to address this potential risk.

8 June 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Battamir UlambayarBattamir Ulambayar
Battamir Ulambayar
Amr Sayed GhanemAmr Sayed Ghanem
Amr Sayed Ghanem
ANAttila Nagy
Attila Nagy
Background/Objectives: Overnutrition, leading to overweight and obesity, is a growing concern among the elderly, contributing to non-communicable diseases. This study examines socio-demographic, dietary, and lifestyle factors associated with overnutrition in Hungarian adults aged 65 and older. Methods: A cross-sectional analysis was conducted using 2019 European Health Interview Survey data, including 1628 elderly participants. Body mass index (BMI ≥ 25 kg/m2) defined overnutrition. Socio-demographic (gender, income, urbanization, partner status), dietary (fruit, vegetable, water, sweetener, salt intake), and lifestyle (alcohol, smoking, physical activity) factors were analyzed. Chi-square tests and multivariate logistic regression identified associations, with odds ratios (ORs) and 95% confidence intervals (CIs) calculated. Results: Overnutrition prevalence was 72.7%, higher in males (77.8%) than females (69.1%). Urbanization, income, and partner status showed associations. Significant predictors included lower water intake (OR = 0.47, 95% CI: 0.33–0.65 for 1–1.5 L), artificial sweetener use (OR = 1.54, 95% CI: 1.13–2.11), moderate/high salt intake (OR = 1.45, 95% CI: 1.06–1.99), former/never smoking (OR = 2.56, 95% CI: 1.73–3.77), and heavy alcohol use (OR = 4.00, 95% CI: 1.33–12.50). Conclusions: Artificial sweetener use, high salt intake, smoking history, and heavy alcohol consumption are key modifiable predictors of overnutrition, informing targeted interventions for elderly Hungarians.

7 August 2025 in Geriatrics
Verified
Journal Article
Open access
PDF file
Battamir UlambayarBattamir Ulambayar
Battamir Ulambayar
Amr Sayed GhanemAmr Sayed Ghanem
Amr Sayed Ghanem
ANAttila Nagy
Attila Nagy
Background: Type 2 diabetes mellitus (T2DM) increases sepsis risk due to immune dysfunction and chronic inflammation. Antidiabetic medications, while primarily used for glycemic control, may modulate sepsis susceptibility through immune and inflammatory pathways. This study investigates the association between antidiabetic medication use and sepsis risk in T2DM patients. Methods: A longitudinal cohort study was conducted using clinical registry data from 5009 T2DM patients at the University Hospital, Debrecen, Hungary (2016–2020). Sepsis cases were identified via ICD-10 code A41, and antidiabetic medication use was categorized using ATC codes. Baseline comorbidities and laboratory parameters were extracted. Chi-square and Wilcoxon rank–sum tests assessed associations between sepsis and categorical/numerical variables, respectively. Time-adjusted multivariate logistic regression evaluated predictors of sepsis risk, with odds ratios (ORs) and 95% confidence intervals (CIs) reported. Results: Age, hypertension, ischemic heart disease, nephropathy, elevated blood glucose, C-reactive protein, and creatinine also independently increased sepsis risk. Insulin use was associated with a 2.6-fold increased sepsis risk (OR = 2.6, 95% CI: 2.09–3.34, p < 0.001), while SGLT2 inhibitors (OR = 0.56, 95% CI: 0.34–0.91, p = 0.02) and GLP-1 receptor agonists (OR = 0.39, 95% CI: 0.19–0.79, p = 0.009) were protective. Conclusions: Insulin-treated patients may require closer infection monitoring, while SGLT2 inhibitors and GLP-1 RAs could be prioritized in high-risk individuals. These findings highlight the potential to inform risk stratification and guide personalized antidiabetic therapy to reduce sepsis risk in T2DM.

24 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ANAttila Nagy
Attila Nagy
ÁTÁgnes Tóth
Ágnes Tóth
NBNatália Bak
Natália Bak
Battamir UlambayarBattamir Ulambayar
Battamir Ulambayar
Amr Sayed GhanemAmr Sayed Ghanem
Amr Sayed Ghanem
FSFerenc Sztanek
Ferenc Sztanek
Background: Sodium–glucose co-transporter 2 (SGLT-2) inhibitors, initially designed for type 2 diabetes, promote glucose excretion and lower blood glucose. Newer analogs like empagliflozin and dapagliflozin improve cardiovascular outcomes through mechanisms other than glycemic control, including blood pressure reduction and anti-inflammatory effects. Given the high cardiovascular risk present in diabetes, our study aims to emphasize the cardioprotective benefits of SGLT-2 inhibitors as a preventive therapy for heart failure (HF) in high-risk T2DM patients. Methods: Using data from 2542 patients identified by the ICD-10 E11 code from 2016 to 2020, this longitudinal study excluded those with E10 codes or those undergoing insulin treatment to focus on non-insulin-dependent T2DM. a multiple logistic regression model assessed HF incidence while adjusting for demographics and HbA1c. Results: SGLT-2 inhibitor use significantly lowered the odds of heart failure events (OR = 0.55, 95% CI: 0.31–0.99, p = 0.046), with a significant difference by gender (OR = 0.45, 95% CI: 0.28–0.71, p = 0.001) and eGFR (OR = 0.98, 95% CI: 0.97–0.99, p = 0.004). Conclusions: The real-world data highlight SGLT-2 inhibitors as promising for HF prevention and broader cardiometabolic health in T2DM, with potential value in managing complex comorbid profiles.